Psychometric validation of the Pyruvate Kinase Deficiency Diary and Pyruvate Kinase Deficiency Impact Assessment in adults in the phase 3 ACTIVATE trial
2023 · Journal of Patient-Reported Outcomes · 2 citations
https://doi.org/10.1186/s41687-023-00650-3